Soleil Securities
http://www.soleilgroup.com/index.shtmlSoleil Securities provides equity research for institutional investors.
View Older Stories View More Recent Stories
-
BIC: Disclosure of total number of voting rights and number of shares forming the capital as of July 31, 2025
-
V Foundation for Cancer Research Wine Celebration Raises $12.3 Million
-
BIC: Disclosure Of Trading In Own Shares for July 2025
-
BIC: Release and availability of the 2025 Half-Year Financial Report
-
BIC: First Half 2025 Results
-
Form 4 Hims & Hers Health, Inc. For: Jul 28 Filed by: Boughton Soleil
-
CIRQUE DU SOLEIL'S FAST CHANNEL NOW AVAILABLE ON THE ROKU CHANNEL
-
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
-
TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities
-
Accor Arrives on The Strip with Treasure Island - TI Las Vegas Hotel & Casino, Handwritten Collection
-
TAIT debuts Feltboard, Bringing the Revolutionary Experience Management Technology to Industry
-
Introducing Bilt’s Home Away from Home Platform: Your Neighborhood Experience Expands to the World's Most Iconic Hotels
-
Scentbird Celebrates the Summer's Most Thrilling Horror Film, "I Know What You Did Last Summer," for a Killer Fragrance Collaboration
-
Form 4 Hims & Hers Health, Inc. For: Jul 14 Filed by: Boughton Soleil
-
BELOVED HOLIDAY SPECTACULAR, CIRQUE DREAMS HOLIDAZE, TO DAZZLE DURING SIX WEEK TOUR THIS HOLIDAY SEASON
-
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
-
Nord Anglia Education's students achieve outstanding 34-point IBDP average, surpassing global scores for 12th consecutive year
-
OCIM Joins LBMA as Full Member
-
Bellagio and Major Food Group Set to Begin a New Chapter of Las Vegas Fine Dining with the Debut of CARBONE Riviera this Fall
-
Fortuna delivers production of 71,229 gold equivalent ounces from ongoing operations for the second quarter of 2025
-
The Messi Experience Officially Launches in Chicago
-
OCIM Restarts Its Two Gold Processing Units in Peru
-
BIC: Disclosure of total number of voting rights and number of shares forming the capital as of June 30, 2025
-
BIC: Half-Year Liquidity Contract Statement
-
BIC: Disclosure Of Trading In Own Shares for June 2025
-
Form 4 Hims & Hers Health, Inc. For: Jun 30 Filed by: Boughton Soleil
-
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
-
MDVIP Grows Presence in Nevada with Primary Care Practices in Las Vegas Valley and Reno
-
Cirque du Soleil Collaborates With The Sandbox to Bring Its Signature Spectacle Into the Metaverse
-
sonnen Pioneers Canada’s First Home Battery-Based VPP Embedded in a Master Planned Community
-
Dorsett Wanchai: Where Hong Kong's Best Family Adventures Begin
-
Dorsett Wanchai: Where Hong Kong’s Best Family Adventures Begin
-
BIC: Evolution in BIC’s Leadership Team
-
BIC: Remuneration of Corporate Officer
-
VidantaWorld Launches Cirque du Soleil LUDŌ, the First Resident Immersive Water Show in Latin America
-
Form 4 Hims & Hers Health, Inc. For: Jun 13 Filed by: Boughton Soleil
-
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
-
MARINELAND DOLPHIN ADVENTURE and DOLPHIN CONNECTION RECEIVE A TOTAL OF SEVEN BOTTLENOSE DOLPHINS FROM GULF WORLD MARINE PARK
-
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
-
Latin Star Soleil & Vivalivetv Join the Kingdom of Kush 32nd Anniversary Gala: A Historic Night of Unity and Culture
-
BIC: Disclosure of total number of voting rights and number of shares forming the capital as of May 31, 2025
-
BIC: Governance Evolution - BIC announces the appointment of Rob Versloot as CEO
-
BIC: Disclosure Of Trading In Own Shares For May 2025
-
Epson Powers Cirque du Soleil's European Residency Debut as Official Projector Partner
-
HGreg donates $55,000 to the Enfant Soleil Telethon
-
Form 4 Hims & Hers Health, Inc. For: May 27 Filed by: Boughton Soleil
-
Epson to Demonstrate High-Impact Visual Experiences with Cutting-Edge Display Technology at InfoComm 2025
-
Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil
-
Juri Biosciences, a TCG Labs Soleil Portfolio Company, and EpimAb Biotherapeutics Enter into a Worldwide Licensing Agreement for KLK2-Directed T-Cell Engager in Metastatic Prostate Cancer
-
Paddles Up: Race into Hong Kong’s Dragon Boat Festival

